RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL
· Real-Time Price · USD
1.90
-0.32 (-14.41%)
At close: Oct 03, 2025, 3:59 PM
1.96
3.16%
Pre-market: Oct 06, 2025, 07:02 AM EDT
RedHill Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 9.55M | 8.8M | 8.04M | 5.88M | 3.71M | 4.22M | 6.53M | 18.76M | 35.74M | 52.3M | 61.8M | 71.07M | 75.13M | 78.29M | 85.76M | 85.15M | 84.48M | 83.88M |
Cost of Revenue | 3.4M | 3.29M | 3.19M | 2.82M | 2.44M | 2.55M | 3.46M | 11.54M | 20.47M | 28.66M | 33.34M | 44.07M | 43.85M | 45.45M | 49.41M | 40.72M | 41.83M | 45.43M |
Gross Profit | 6.16M | 5.5M | 4.85M | 3.06M | 1.26M | 1.67M | 3.07M | 7.22M | 15.28M | 23.64M | 28.46M | 27M | 31.28M | 32.84M | 36.35M | 44.42M | 42.65M | 38.45M |
Operating Income | -10.54M | -12.58M | -14.61M | -17.55M | -20.49M | -20.67M | 12.63M | 8.7M | 7.62M | 2.87M | -42.84M | -53.59M | -63.88M | -79.61M | -81.14M | -80.14M | -77.21M | -64.82M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 7.09M | 28.68M | 28.68M | 31.87M | 26.43M | 4.86M | 4.87M | 1.7M | 54K | 86K | 4.48M | 4.51M | 4.6M |
Pretax Income | -9.31M | -8.79M | -8.27M | -19.22M | -30.17M | -27.87M | 23.92M | 33.73M | 11.57M | -900K | -71.67M | -92.31M | -78M | -95.41M | -97.74M | -97.7M | -94.95M | -81.88M |
Net Income | -9.31M | -8.79M | -8.27M | -19.22M | -30.17M | -27.87M | 23.92M | 33.73M | 11.57M | -900K | -71.67M | -92.31M | -78M | -95.41M | -97.74M | -97.7M | -94.95M | -81.88M |
Selling & General & Admin | 12.45M | 13.98M | 15.52M | 18.24M | 20.96M | 24.55M | 30.98M | 37.99M | 45.58M | 54.56M | 64.03M | 68.58M | 78.94M | 87.38M | 87.99M | 94.75M | 91.53M | 82.06M |
Research & Development | 1.89M | 1.74M | 1.59M | 1.72M | 1.86M | 2.77M | 3.53M | 4.06M | 5.08M | 5.3M | 7.28M | 12.01M | 16.22M | 25.08M | 29.5M | 29.82M | 28.32M | 21.21M |
Other Expenses | 2.36M | 2.36M | 2.36M | 644K | -1.07M | -4.98M | -44.06M | -43.53M | -42.99M | -39.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 16.7M | 18.08M | 19.46M | 20.61M | 21.75M | 22.34M | -9.56M | -1.48M | 7.66M | 20.77M | 71.31M | 80.59M | 95.16M | 112.45M | 117.49M | 124.57M | 119.86M | 103.27M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 1.93M | 2.35M | 3.77M | 35.56M | 37.84M | 41.33M | 43.5M | 15.72M | 15.76M | 16.6M | 13.01M | 13.22M | 12.63M |
Selling & Marketing Expenses | 4.5M | 5.22M | 5.95M | 7.28M | 8.61M | 11.39M | 14.76M | -7.67M | -3.14M | 1.61M | 9.06M | -4.34M | 4.09M | 10.05M | 11.38M | 20.38M | 18.27M | 13M |
Cost & Expenses | 20.09M | 21.37M | 22.66M | 23.43M | 24.2M | 24.89M | -6.1M | 10.06M | 28.13M | 49.43M | 104.64M | 124.67M | 139.01M | 157.9M | 166.89M | 165.29M | 161.69M | 148.7M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.8M | 1.8M | 2.58M | 2.58M | 2.35M | 2.35M | 780.9K | 548.13K | 315.36K | 194.8K | 186.39K | 127.67K | 113.66K | 105.37K | 99.84K | 93.58K | 93.36K | 85.92K |
Shares Outstanding (Diluted) | 1.8M | 1.8M | 2.58M | 2.58M | 2.35M | 2.35M | 780.9K | 548.13K | 315.36K | 194.8K | 186.39K | 127.67K | 113.66K | 105.37K | 99.84K | 93.58K | 93.36K | 85.92K |
EPS (Basic) | -4 | -4 | -4 | -20 | -43 | -39 | 218.00 | 215.00 | -43 | -149 | -600 | -824 | -770 | -979 | -1K | -1.1K | -1.1K | -1.1K |
EPS (Diluted) | -4 | -4 | -4 | -20 | -43 | -39 | 218.00 | 215.00 | -43 | -149 | -600 | -824 | -770 | -979 | -1K | -1.1K | -1.1K | -1.1K |
EBITDA | -7.91M | -9.82M | -11.73M | -15.69M | -19.51M | -12.81M | 102.36M | 107.9M | 111.71M | 103.45M | -22.18M | -31.48M | -44.69M | -61.68M | -62.99M | -70.94M | -67.74M | -55.37M |
EBIT | -8.18M | -10.22M | -12.25M | -16.37M | -20.49M | -13.58M | 41.31M | 45.03M | 47.13M | 36.95M | -30.34M | -48.81M | -62.28M | -79.65M | -81.14M | -80.45M | -77.48M | -65.01M |
Depreciation & Amortization | 278.5K | 403.5K | 528.5K | 682.5K | 979.67K | -58.13M | 2.15M | 3.98M | 5.68M | 66.5M | 8.15M | 17.34M | 17.59M | 17.97M | 18.15M | 9.51M | 9.74M | 9.64M |